Previous Article | Next Article ![]()
Infection and Immunity, October 2006, p. 5487-5496, Vol. 74, No. 10
0019-9567/06/$08.00+0 doi:10.1128/IAI.01934-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Jörg Schmidt,1
Cristiana Santos de Macedo,1,
Michael A. J. Ferguson,3 and
Ralph T. Schwarz1,4
Institut für Virologie, AG Parasitologie, Hans-Meerwein Strasse 2, D-35043 Marburg, Germany,1 Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia,2 Division of Biological Chemistry and Molecular Microbiology, The University of Dundee, DD1 5EH Dundee, Scotland, United Kingdom,3 Unité de Glycobiologie Structurale et Fonctionnelle UMR CNRS/USTL no. 8576-IFR 118, Université des Sciences et Technologies de Lille C9, F-59655 Villeneuve D'Ascq, France4
Received 25 November 2005/ Returned for modification 22 February 2006/ Accepted 10 July 2006
Plasmodium falciparum malaria kills roughly 2.5 million people, mainly children, annually. Much of this mortality is thought to arise from the actions of a malarial toxin. This toxin, identified as glycosylphosphatidylinositol (GPI), is a major pathogenicity determinant in malaria. A malarial molecule, Pfj, labeled by [3H]glucosamine like the GPIs, was identified as a non-GPI molecule. Here we show that Pfj is able to down-regulate tumor necrosis factor alpha (TNF-
) production induced by the GPI of P. falciparum. Mass spectrometry analysis showed that Pfj was not a single molecule but represented a number of molecules. Separation methods, such as cation-exchange chromatography and thin-layer chromatography, were used to isolate and identify the following four main fatty acids responsible for the inhibitory effect on TNF-
production: myristic, pentadecanoic, palmitic, and palmitoleic acids. This regulatory effect on cytokine production suggests that there is balanced bioactivity for the different categories of malarial lipids.
Present address: Laboratory for Organic Chemistry, ETH, Wolfgang-Pauli-Str. 10, CH-8093 Zurich, Switzerland.
Present address: UNIDERP-Rua Ceará, 333-CEP 79003-010 Campo Grande, MS, Brazil.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|